,file,ref_number,ref_text,doi,doi_url
0,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_1,[1],"Hechtman JF, Polydorides AD. 2012. Histopathological features of colorectal carcinomas. Gastroenterol Clin North Am. 41(3): 629-49.",10.3410/f.717973188.793470321,https://doi.org/10.3410/f.717973188.793470321
1,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_1,[2],National Comprehensive Cancer Network. 2021. Rectal Cancer (Version 6.2021).,10.6004/jnccn.2007.0081,https://doi.org/10.6004/jnccn.2007.0081
2,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_1,[3],"Topalian SL, Taube JM, Anders RA, Pardoll DM. 2016. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 16(5): 275-87.",10.1038/nrc.2016.36,https://doi.org/10.1038/nrc.2016.36
3,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_1,[4],"Ribas A, Wolchok JD. 2018. Cancer immunotherapy using checkpoint blockade. Science. 359(6382): 1350-5.",10.1126/science.aar4060,https://doi.org/10.1126/science.aar4060
4,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_1,[5],"Quail DF, Joyce JA. 2013. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19(11): 1423-37.",10.1038/nm.3394,https://doi.org/10.1038/nm.3394
5,experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_1,[6],"Balkwill FR, Capasso M, Hagemann T. 2012. The tumor microenvironment at a glance. J Cell Sci. 125(Pt 23): 5591-6.",10.1242/jcs.116392,https://doi.org/10.1242/jcs.116392
